A detailed history of Nkcfo LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nkcfo LLC holds 780 shares of MRK stock, worth $77,360. This represents 0.04% of its overall portfolio holdings.

Number of Shares
780
Previous 1,545 49.51%
Holding current value
$77,360
Previous $191,000 53.4%
% of portfolio
0.04%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$111.15 - $128.97 $85,029 - $98,662
-765 Reduced 49.51%
780 $89,000
Q4 2022

Jan 26, 2023

BUY
$87.44 - $112.11 $135,094 - $173,209
1,545 New
1,545 $171,000
Q4 2020

Jan 28, 2021

SELL
$71.77 - $79.65 $1.7 Million - $1.88 Million
-23,625 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $1.5 Million - $2.07 Million
23,625 New
23,625 $1.82 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Nkcfo LLC Portfolio

Follow Nkcfo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nkcfo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nkcfo LLC with notifications on news.